PFE - GSK unit ViiV raises outlook on long-term HIV therapies
2023-09-29 07:16:33 ET
More on GSK
- Merck Vs. GSK: The Game-Changer Race In Pharma Excellence
- GSK plc (GSK) BofA Global Healthcare Conference (Transcript)
- GSK plc (GSK) Citi's 18th Annual BioPharma Conference Transcript
- Wave Life Sciences spikes on R&D Day
- Scynexis recalling antifungal therapy on potential contamination
For further details see:
GSK unit ViiV raises outlook on long-term HIV therapies